Zacks: Moleculin Biotech Inc (MBRX) Given Average Recommendation of...


Moleculin Biotech Inc has earned an average broker rating score of 1.00 from the one analysts that provide coverage for the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy recommendation.



from Biotech News